Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 Hydroxyquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104326977A details a novel route for 6,7-diethyl-4-hydroxyquinoline offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1329598A reveals a mild base-catalyzed decarboxylation route for 4-hydroxyquinolines, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN110845406A reveals a safer quinoline synthesis avoiding phosphorus oxychloride. Ideal for tyrosine kinase inhibitor manufacturing with reduced waste and high purity.
Novel one-pot reductive cyclization method for high-purity quinoline intermediates. Reduces steps, eliminates column chromatography, suitable for scale-up.
Discover the novel synthesis of 1-R-4-amino-1,2,3,4-tetrahydroquinoline from 4-hydroxyquinoline. A scalable, cost-effective route for API intermediates avoiding harsh Friedel-Crafts conditions.
Patent CN113416166B details a green silver-catalyzed route using CO2 and ionic liquids for high-purity pharmaceutical intermediates with simplified workup.
Patent CN112469711A reveals a high-purity synthesis route for quinoline derivatives, eliminating column chromatography and reducing impurities for scalable API intermediate manufacturing.
Patent CN108794396A details efficient oxidation of 4-oxo-2,3-dihydroquinolines. Offers high yield, low cost, and scalable supply chain solutions for pharmaceutical intermediates.